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Abstract
The fatty acid composition of plasma lipids was deter-
mined in 41 pairs of mothers and their term infants at
time of birth (38–42 postmenstrual weeks) by high-reso-
lution capillary gas-liquid chromatography. Linoleic and
·-linolenic acids were found at smaller concentrations in
cord than in maternal triglycerides, in contrast to strik-
ingly higher proportions of their long-chain polyunsatu-
rated metabolites (LC-PUFA), which indicates a preferen-
tial maternofetal transport for certain physiologically im-
portant LC-PUFA. While no significant gestational age-
dependent changes occurred in maternal plasma triglyc-
erides, the values for most of the fetal long-chain n–3
metabolites increased with the duration of gestation,
possibly reflecting an increased transplacental fatty acid
passage during late pregnancy or a maturation of de-
saturation in the fetal liver.
Copyright © 2000 S. Karger AG, Basel
Introduction
Fetal tissue growth and development require the provi-
sion of essential fatty acids (EFA) transported across the
placenta [1]. Daily intrauterine accretion per kilogram of
body weight of term-born babies has been estimated as
about 400 mg n–6 fatty acids and 50 mg n–3 fatty acids,
respectively [2]. The main sources for placental fatty acid
transport are considered nonesterified fatty acids (NEFA)
derived from triglycerides (TG) of maternal adipose tis-
sue and hepatic lipoproteins (VLDL) [3]. The parent fatty
acids linoleic (C18:2n–6) and ·-linolenic (C18:3n–3)
acids are partially converted into long-chain polyunsatu-
rated fatty acids (LC-PUFA) of the n–6 and n–3 series.
LC-PUFA biosynthetic routes comprise alternating chain
elongation, hepatic desaturation and peroxisomal ß-oxi-
dation [4–6]. LC-PUFA are important for the formation
of membrane structures in all tissues and are precursors of
prostaglandins and eicosanoids. The rapidly developing
brain in the last trimester and the first postnatal months
may be especially vulnerable to a poor LC-PUFA status
[1, 7, 8]. Marginal EFA status was shown to impair neural
development in early infancy [9]. Therefore, elucidation
of the physiological regulation of the EFA and LC-PUFA
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status of newborn infants and their gestational age-depen-
dency in late pregnancy is of special interest. Gestational
age-dependent fatty acid content of maternal and cord
plasma with packed column gas chromatography has been
reported [10], but this method has a limited separation
power and accuracy. We examined the fatty acid compo-
sition of cord and maternal plasma NEFA, TG, phospho-
lipids (PL) and cholesterolesters (CE) at delivery taking
advantage of the much higher separating power of capil-
lary gas chromatography.
Subjects and Methods
The study protocol was approved by the local ethical review com-
mittee, and informed consent was obtained from the participating
mothers. The study population comprised 41 pairs of mothers and
their term-born infants (38–42 postmenstrual weeks) (table 1). All
children appeared healthy, and there was no indication of any inher-
ited or intrauterine acquired disease or malformation. All participat-
ing mothers were free of risk factors for placental dysfunction such as
diabetes mellitus, gestational diabetes or hypertension, and were
screened for proteinuria and edema.
Blood was drawn at the time of birth from a peripheral vein of the
mother and by venipuncture from the placental portion of the umbil-
ical cord immediately after its clamping. Na-EDTA was used as anti-
coagulant. The samples were centrifuged immediately and stored at
–20°C until analysis. Plasma lipids were extracted from 0.25 ml
plasma into chloroform/methanol (2:1) after addition of internal
standard [11]. PL, TG, CE and NEFA were separated by thin–layer
chromatography (TLC) on silica gel plates (Merck, Darmstadt, Ger-
many) with two full developments in petroleum ether/ether/acetic
acid (75:25:1, by vol) and then one 5-cm run of chloroform/metha-
nol/water (65:25:4, by vol). Fatty acids were transesterified with
methanolic hydrochloric acid, and fatty acid-methyl esters separated
by capillary gas-liquid chromatography on a Hewlett-Packard 5890
Series II gas chromatograph, equipped with a 50 m ! 0.32 mm (in-
ner diameter) polar cyanopropil silicone-coated column (SGE, Wei-
terstadt, Germany). Fatty acid determinations were performed at a
column–head pressure of 1.3 bar and an initial temperature of
130°C, followed by an increase of 3 °C/min to 180°C, consecutively
raised to 220°C at 4°C/min. Fatty acid methyl esters were identified
by comparison with authentic standards (Nu-Chek-Prep, Minnesota,
USA).
Results were evaluated with Minitab for Windows, Release 9.2
(Minitab, Pennsylvania State University, USA) and expressed as per-
centage values (% w/w) of all detected fatty acids with a chain length
of 12–24 carbon atoms. All data are presented as median and inter-
quartile range values because some appeared not to be normally dis-
tributed. Maternal and cord plasma results were compared by
Mann–Whitney’s two-sided rank test. Gestational age dependency
was studied by linear least-square regression analysis. The level of
statistical significance was set at p ! 0.05.
Fig. 1. Distribution of newborns in different age groups (days post-
menstruationem).
0
260 270 280
Days
290 300
10
20
Fr
eq
u
en
cy
Table 1. Characteristics of the study population, median (interquar-
tile range)
Maternal age, years 30.0 (7.5)
Maternal weight prior to birth, kg 65.0 (14.0)
Maternal weight at birth, kg 77.0 (12.5)
Maternal length, cm 168.5 (8.0)
Maternal body mass index at birth, kg/m2 22.6 (4.8)
Duration of pregnancy, days p.m. 282.0 (12.5)
Infants’ birth weight, g 3,490.0 (670.0)
Infants’ birth length, cm 51.0 (3.0)
Results
Characteristics of our study population are shown in
table 1 and figure 1. Total fatty acid concentrations were
significantly higher in maternal than in cord plasma TG
(table 2). While the median percentages of C18:3n–3 and
C18:2n–6 were markedly lower in fetal than in maternal
plasma TG, the values for most of the long-chain n–6 and
n–3 metabolites were significantly higher in the cord sam-
ples. Therefore, although total EFA values were lower in
fetal TG, total cord LC-PUFA percentages were distinc-
tively higher than those in maternal plasma, resulting in a
greater C20:4n–6/C18:2n–6 and C22:6n–3/C18:3n–3 ra-
tio in cord plasma TG.
Neither total values nor individual fatty acid percent-
ages from maternal plasma NEFA, TG, PL and CE
C18:2n–6
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Table 2. Fatty acid composition of maternal and cord plasma TG (% w/w) and gestational age dependency of cord
plasma TG
Maternal plasma
(n = 41)
median ir
Cord plasma
(n = 41)
median ir p ! 0.05
Gestational age dependency
of cord plasma TG
r p ! 0.05
11.91 (5.48) 10.05 (3.45) + 0.243
C18:3n–6 0.14 (0.08) 0.45 (0.15) + 0.219
C20:2n–6 0.28 (0.11) 0.31 (0.18) 0.009
C20:3n–6 0.22 (0.07) 0.81 (0.43) + 0.441 +
C20:4n–6 0.75 (0.29) 2.92 (1.11) + 0.127
C22:4n–6 0.11 (0.05) 0.57 (0.31) + 0.204
Total n–6-LC-PUFA 1.54 (0.41) 5.74 (2.20) + –0.119
Total n–6 13.88 (5.90) 15.82 (4.20) + 0.135
C18:3n–3 0.52 (0.19) 0.20 (0.27) + 0.536
C20:3n–3 0.05 (0.06) 0.00 (0.00) –
C20:5n–3 0.06 (0.04) 0.00 (0.17) 0.242
C22:5n–3 0.09 (0.04) 0.12 (0.32) 0.564 +
C22:6n–3 0.32 (0.22) 1.33 (1.27) + 0.371 +
Total n–3-LC-PUFA 0.51 (0.28) 1.59 (1.66) + 0.453 +
Total n–3 1.09 (0.39) 1.82 (1.79) + 0.500 +
Total LC-PUFA 2.03 (0.52) 7.38 (2.54) + 0.119
n–6-/n–3-LC-PUFA 3.11 (1.62) 3.10 (5.28) –0.402 +
C18:2n–6/C18:3n–3 22.78 (8.38) 44.80 (15.89) + –0.287
C20:4n–6/C18:2n–6 0.06 (0.02) 0.29 (0.11) + 0.000
C22:6n–3/C18:3n–3 0.61 (0.48) 6.32 (4.75) + –0.037
Total (mg/dl) 143.31 (63.73) 24.27 (12.43) + 0.455 +
ir = interquartile range, r = correlation coefficient.
showed significant gestational age-dependent changes
(data not shown). No significant gestational age-depen-
dent changes could be observed in cord plasma NEFA, PL
and CE (data not shown), but total fatty acid concentra-
tions in fetal plasma TG significantly increased with
advancing gestation (table 2). The median percentage of
C18:3n–3 showed no significant gestational age depen-
dency in cord plasma TG, but the values for most of the
long-chain n–3 metabolites increased significantly with
the duration of gestation. In contrast to n–3 LC-PUFA,
the majority of the long-chain n–6 metabolites were not
correlated to gestational age, resulting in a negative corre-
lation of the n–6/n–3 LC-PUFA ratio and the duration of
pregnancy.
Discussion
In agreement with other studies [12–14], we found the
percentage values of C18:3n–3 and C18:2n–6 markedly
lower in cord than in maternal plasma TG. In addition to
a limited placental transfer, possible higher rates of plas-
ma clearance for storage or metabolism in placental and
fetal tissue may have contributed to the low cord plasma
levels. While C18:3n–3 and C18:2n–6 can be further
desaturated in the ovine placenta [15], human placental
tissue shows no activity of both the ¢6- and ¢5-desatu-
rases [16]. Therefore, LC-PUFA in the fetal circulation
appear to be synthesized either by the mother or the fetus.
Although LC-PUFA biosynthesis is active in the new-
born, the biosynthesis capacity appears to be limited [4].
Infants, fed formulas with precursor EFA but lacking LC-
PUFA showed a more pronounced decline in LC-PUFA
status than breast-fed infants [1, 17]. Thus, the high pro-
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portion of LC-PUFA in cord plasma appears to result pri-
marily from a preferential maternal-fetal transfer rather
than from an active fetal LC-PUFA synthesis [18]. A pref-
erential LC-PUFA transfer may be explained either by an
enhanced placental transport of polyunsaturated fatty
acids [19] or by a selective placental utilisation of mater-
nal lipid fractions with a high LC-PUFA content [20].
Gestational age-dependent increase of fetal plasma TG
has been reported [10, 21, 22]. Although animal tissues
are capable of synthesizing LC-PUFA at an early stage of
development [23], deposition of fat in human fetal adi-
pose tissue takes place mainly in the last month of preg-
nancy [21]. There is evidence in the monkey that the pla-
centa becomes more permeable to the passage of fatty
acids from the mother to the fetus as pregnancy advances
[24]. This might be explained by an increased blood per-
fusion of placental tissue in late gestation. If this was the
only underlying reason for the gestational age-dependent
increase of human fetal plasma LC-PUFA, it remains
unclear why a gestational age-dependent increase can only
be observed in cord TG but not in other fetal lipid classes
like NEFA, CE or PL. Circulating NEFA are mainly
derived from lipolysis of TG prior to being transported to
the fetus, liberation of fatty acids from adipose tissue is
considered to be low in the newborn. Fetal plasma CE are
predominantly synthesized by circulating lecithin–choles-
terol acyltransferase (LCAT) that transfers fatty acids
from phosphatidylcholine to cholesterol. Low LCAT ac-
tivity in the fetal liver may be the cause for the constancy
of fetal CE-LC-PUFA during late gestation. PL are main
components of biological membranes and are steadily
incorporated into fetal lipid structures as pregnancy ad-
vances, this might prevent a gestational age-dependent
accumulation of PL-LC-PUFA in the fetal plasma. Circu-
lating TG are derived from both exogenous lipids after
transplacental passage and endogenous lipids as hepatic
VLDL [3]. In addition to an increased placental fatty acid
transfer in late gestation, it seems that endogenous synthe-
sis of fatty acids by the fetus appears to account for the
fetal TG-LC-PUFA accumulation [16]. Maintenance of
plasma TG levels in term and premature infants during
the first postnatal day shows that at least during late gesta-
tion the fetal liver is capable of VLDL secretion [25].
Moreover, desaturation and chain elongation of both,
C18:2n–6 and C18:3n–3 respectively, is possible in the
fetal liver, but the substrate specifity of the the ¢6-desatu-
rase is much higher for C18:3n–3 than for C18:2n–6 [26],
possibly reflecting the gestational age-related gradual in-
crease of TG-LC-PUFA of the n–3 series in contrast to
stable levels of most of the n–6 LC-PUFA in cord TG dur-
ing late gestation. Hence, the gestational age-related grad-
ual increase of n–3 LC-PUFA in fetal TG may be caused
by a combination of increased transplacental fatty acid
passage in late pregnancy and a maturation of the desatu-
rase activity in the fetal liver during late gestation.
Acknowledgement
We are grateful for the support of participating mothers and the
staff of the Department of Gynaecology and Obstetrics. This study
was financially supported in part by Deutsche Forschungsgemein-
schaft, Bonn, Germany (Ko 912/5–2).
References
1 Koletzko B: Importance of dietary lipids; in
Tsang R, Zlotkin S, Nichols B, Hansen J (eds):
Nutrition During Infancy: Birth to 2 Years.
Cincinnati, Observatory Group, 1997.
2 Clandinin MT, Chappel JE, Heim T, Swyer
PR, Chance GW: Fatty acid utilisation in peri-
natal de novo synthesis of tissues. Early Hum
Dev 1985;5:355–366.
3 King KC, Adam PAJ, Laskowski DE, Schwartz
R: Sources of fatty acids in the newborn. Pedi-
atrics 1971;47:192–198.
4 Demmelmair H, von Schenk U, Behrendt E,
Sauerwald T, Koletzko B: Estimation of arachi-
donic acid synthesis in fullterm neonates using
natural variation of 13C-abundance. J Pediatr
Gastroenterol Nutr 1995;21:31–36.
5 Sprecher H: Biochemistry of essential fatty
acids. Prog Lipid Res 1981;20:13–22.
6 Voss A, Reinhart M, Sankarappa S, Sprecher
H: The metabolism of 7, 10, 13, 16, 19-docosa-
pentaenoic acid to 4, 7, 10, 13, 16, 19-docosa-
hexaenoic acid in rat liver is independent of a
4-desaturase. J Biol Chem 1991;266:19995–
20000.
7 Farquharson J, Cockburn F, Patrick WA,
Jamieson EC, Logan RW: Infant cerebral cor-
tex phospholipid fatty-acid composition and
diet. Lancet 1992;340: 810–813.
8 Martinez M: Tissue levels of polyunsaturated
fatty acids during early human development. J
Pediatr 1992;120:129–138.
9 Agostoni C, Trojan S, Bellù R, Riva E, Giovan-
nini M: Neurodevelopmental quotient of
healthy term infants at 4 months and feeding
practice: The role of long-chain polyunsaturat-
ed fatty acids. Pediatr Res 1995;38:262–266.
10 Friedman Z, Danon A, Lamberth EL, Mann
WJ: Cord blood fatty acid composition in in-
fants and in their mothers during the third tri-
mester. J Pediatr 1978;92:461–466.
11 Folch J, Lees M, Sloane Stanley GH: A simple
method for the isolation and purification of
total lipides from animal tissues. J Biol Chem
1957;226:497–509.
12 Hendrickse W, Stammers JP, Hull D: The
transfer of free fatty acids across the human
placenta. Br J Obstet Gynecol 1985;92:945–
952.
13 Koletzko B, Müller J: Cis- and trans-isomeric
fatty acids in plasma lipids of newborn infants
and their mothers. Biol Neonate 1990;57:172–
178.
100 Biol Neonate 2000;77:96–100 Berghaus/Demmelmair/Koletzko
14 Olegard R, Svennerholm L: Fatty acid compo-
sition of plasma and red cell phosphoglycerides
in full term infants and their mothers. Acta
Paediatr Scand 1970;59:637–647.
15 Noble RC, Shand HJ, Christie WW: Synthesis
of C20 and C22 polyunsaturated fatty acids by
the placenta of the sheep. Biol Neonate 1987;
47:333–387.
16 Chambaz J, Ravel D, Manier MC, Pepin D,
Mulliez N, Bereziat G: Essential fatty acids
interconversion in the human fetal liver. Biol
Neonate 1985;47:136–140.
17 Carlson SE, Rhodes PG, Ferguson MG: Doco-
sahexaenoic acid status of preterm infants at
birth and following feeding with human milk or
formula. Am J Clin Nutr 1986; 44:798–804.
18 Berghaus TM, Demmelmair H, Koletzko B:
Fatty acid composition of lipid classes in ma-
ternal and cord plasma at birth. Eur J Pediatr
1998;157:763–768.
19 Dancis J, Jansen V, Kayden HJ, Schneider H,
Levitz M: Transfer across perfused human pla-
centa. II. Free fatty acids. Pediatr Res 1973;7:
192–197.
20 Kuhn DC, Crawford MA, Stevens P: Transport
and metabolism of essential fatty acids by the
human placenta. Contrib Gynec Obstet 1985;
13:139–140.
21 Fosbrooke AS, Wharton BA: Plasma lipids in
umbilical cord blood from infants of normal
and low birth weight. Biol Neonate 1973;23:
330–338.
22 Hoving EB, van Beusekom CM, Nijeboer HJ,
Muskiet FAJ: Gestational age dependency of
essential fatty acids in cord plasma cholesterol
esters and triglycerides. Pediatr Res 1994;35:
461–469.
23 Roux JF: Lipid metabolism in the fetal and
neonatal rabbit. Metabolism 1966;15: 856–
864.
24 Portman OW, Behrman RE, Soltys P: Transfer
of free fatty acids across the primate placenta.
Am J Physiol 1969;226:143–147.
25 Christensen NC: Free fatty acids, glycerol and
triglycerides during the first 24 hours in infants
with a birth weight ^2700 gramms. Acta Pae-
diatr Scand 1981; 70:485–490.
26 Rodriguez A, Sarda P, Nessmann C, Boulot P,
Leger CL, Descomps B: ¢6- and ¢5-desaturase
activities in the human fetal liver: Kinetic as-
pects. J Lipid Res 1998; 39:1825–1832.
